Reuters: The U.S. drugmaker hopes to takeover Britain’s AstraZeneca Plc.
Reuters: The U.S. drugmaker hopes to takeover Britain’s AstraZeneca Plc.
Pfizer said on Monday it made a 58.8 billion pounds ($98.9 billion) bid approach to AstraZeneca in January and had contacted its British rival again on April 26, seeking to further discuss a takeover.
Buying AstraZeneca would boost Pfizer’s pipeline of cancer drugs and create significant cost and tax savings.
Read more here.
